Name of the Procedure:

Injection, Immune Globulin (Cuvitru), 100 mg
Common Names: Cuvitru Injection, Subcutaneous Immunoglobulin Therapy
Medical Terms: Subcutaneous Immune Globulin (SCIG) Administration

Summary

This procedure involves an injection of a medication called immune globulin. Cuvitru is administered to help bolster the immune system in individuals with immune deficiencies. The injection is typically given under the skin (subcutaneously).

Purpose

Cuvitru is used to treat patients with primary immunodeficiency (PI), a condition where the body's immune system doesn’t function properly. The goal is to boost the immune system’s ability to fight infections and to improve the patient’s overall health and quality of life.

Indications

• Patients with primary immunodeficiency diseases.
• Individuals suffering from recurrent infections due to immune system deficiencies.
• Those diagnosed with conditions like Common Variable Immunodeficiency (CVID).

Preparation

• No specific fasting is required.
• Patients may need to discuss any current medications with their healthcare provider.
• An allergy test for immune globulin might be conducted.
• Ensure the injection site (usually the abdomen or thigh) is clean.

Procedure Description

1. The healthcare professional will clean the injection site with an antiseptic solution.
2. The necessary dose of Cuvitru will be prepared in a syringe.
3. The syringe will be attached to an infusion pump or manually injected subcutaneously.
4. The medication will be slowly administered over a specified period.
5. The site of injection might be massaged gently to aid absorption.

Tools and Equipment: Syringe, infusion pump (if used), antiseptic solution, sterile gloves.

Anesthesia or Sedation: Generally not required; a topical numbing cream may be used to reduce discomfort.

Duration

The procedure typically takes about 1 to 2 hours, including preparation and administration.

Setting

Cuvitru injections can be administered in various settings such as a hospital, outpatient clinic, or even at home under the supervision of a healthcare professional.

Personnel

• Registered Nurse (RN)
• Physician (to prescribe and oversee treatment)
• Pharmacist (to prepare the medication)

Risks and Complications

Common Risks:

• Minor swelling or redness at the injection site
• Mild discomfort or pain during the injection

Rare Complications:

• Severe allergic reactions (anaphylaxis)
• Infection at the injection site
• Headache, fatigue, or nausea

Management: Immediate medical attention in case of severe reactions, and symptomatic treatment for minor issues.

Benefits

• Improved immune system function
• Reduced frequency and severity of infections
• Enhanced overall health and reduced hospital visits

Timeline for Benefits: Patients may start to notice improvements within a few weeks of regular treatments.

Recovery

• Patients can resume normal activities almost immediately.
• Post-procedure care includes observing the injection site for signs of infection.
• Follow-up appointments may be scheduled to monitor response to treatment.

Alternatives

• Intravenous Immune Globulin (IVIG) therapy
• Prophylactic antibiotics for infection prevention
• Bone marrow or stem cell transplant (in severe cases)

Pros and Cons:

• IVIG: More invasive and requires hospital visits but less frequent dosing.
• Cuvitru: Can be done at home and less invasive but requires regular administration.
• Prophylactic Antibiotics: Prevent infections but do not address the underlying immune deficiency.

Patient Experience

Patients might feel a slight pinch or stinging during the injection. Minor discomfort or swelling at the injection site can occur but is usually short-lived. Pain management might include OTC pain relievers or topical remedies as recommended by the healthcare provider. Most patients can return to their regular activities shortly after the procedure.